Roles of TGF-β family signals in the fate determination of pluripotent stem cells

Seminars in Cell and Developmental Biology

Volumn 32, Issue , 2014, Pages 98-106

  Itoh, Fumiko ^a   Watabe, Tetsuro ^a,b   Miyazono, Kohei ^c  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

BMP; Differentiation; ES cells; IPS cells; Pluripotency; TGF

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; GROWTH DIFFERENTIATION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NODAL SIGNALING PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SMAD PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; GERM CELL; GERM LAYER; HUMAN; MESODERM; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

IPS;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84904460051     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.05.017     Document Type: Review

References (97)

1. Sakaki-Yumoto M., Katsuno Y., Derynck R. TGF-β family signaling in stem cells. Biochim Biophys Acta 2013, 1830:2280-2296.
2. Derynck R., Miyazono M. The TGF-β family 2008, Cold Spring Harbor Laboratory Press, NY. R. Derynck, M. Miyazono (Eds.).
3. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limon P. The polarization of immune cells in the tumour environment by TGFβ. Nat Rev Immunol 2010, 10:554-567.
4. Heldin C.H., Landstrom M., Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009, 21:166-176.
5. Moustakas M., Miyazawa K. TGF-β in human disease 2013, Springer. M. Moustakas, K. Miyazawa (Eds.).
6. Oshimori N., Fuchs E. Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. Cell Stem Cell 2012, 10:63-75.
7. Massagué J., Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett 2012, 586:1953-1958.
8. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshal V.S., et al. Embryonic stem cell line derived from human blastocysts. Science 1998, 282:1145-1147.
9. Stojkovic M., Lako M., Stojkovic P., Stewart R., Przyborski S., Armstrong L., et al. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells 2004, 22:790-797.
10. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
11. Brons I.G., Smithers L.E., Trotter M.W., Rugg-Gunn P., Sun B., Chuva de Sousa Lopes S.M., et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448:191-195.
12. Loh K.M., Lim B. A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell 2011, 8:363-369.
13. Silva J., Smith A. Capturing pluripotency. Cell 2008, 132:532-536.
14. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
15. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95:379-391.
16. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
17. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006, 44:533-538.
18. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
19. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006, 38:431-440.
20. Wei C.L., Miura T., Robson P., Lim S.K., Xu X.Q., Lee M.Y., et al. Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells 2005, 23:166-185.
21. Oh S.K., Kim H.S., Park Y.B., Seol H.W., Kim Y.Y., Cho M.S., et al. Methods for expansion of human embryonic stem cells. Stem Cells 2005, 23:605-609.
22. Evans M., Kaufman M. Establishment in culture of pluripotent cells from mouse embryos. Nature 1981, 292:154-156.
23. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988, 336:688-690.
24. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988, 336:684-687.
25. Niwa H., Ogawa K., Shimosato D., Adachi K. A parallel circuit of LIF signaling pathways maintains pluripotency of mouse ES cells. Nature 2009, 460:118-122.
26. Ernst M., Novak U., Nicholson S.E., Layton J.E., Dunn A.R. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3. J Biol Chem 1999, 274:9729-9737.
27. Ying Q.L., Nichols J., Chambers I., Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003, 115:281-292.
28. Romero-Lanman E.E., Pavlovic S., Amlani B., Chin Y., Benezra R. Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. Stem Cells Dev 2012, 21:384-393.
29. Costa Y., Ding J., Theunissen T.W., Faiola F., Hore T.A., Shliaha P.V., et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 2013, 495:370-374.
30. Liu N., Lu M., Tian X., Han Z. Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells. J Cell Physiol 2007, 211:279-286.
31. Kunath T., Saba-El-Leil M.K., Almousailleakh M., Wray J., Meloche S., Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 2007, 134:2895-2902.
32. Li Z., Fei T., Zhang J., Zhu G., Wang L., Lu D., et al. BMP4 signaling acts via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. Cell Stem Cell 2012, 10:171-182.
33. Ginis I., Luo Y., Miura T., Thies S., Brandenberger R., Gerecht-Nir S., et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004, 269:360-380.
34. Xu R.H., Peck R.M., Li D.S., Feng X., Ludwig T., Thomson J.A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2005, 2:185-190.
35. Beattie G.M., Lopez A.D., Bucay N., Hinton A., Firpo M.T., King C.C., et al. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 2005, 23:489-495.
36. James D., Levine A.J., Besser D., Hemmati-Brivanlou A. TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005, 132:1273-1282.
37. Besser D. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. J Biol Chem 2004, 279:45076-45084.
38. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005, 118:4495-4509.
39. Xu R.H., Sampsell-Barron T.L., Gu F., Root S., Peck R.M., Pan G., et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008, 3:196-206.
40. Sirard C., de la Pompa J.L., Elia A., Itie A., Mirtsos C., Cheung A., et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 1998, 12:107-119.
41. Conlon F.L., Lyons K.M., Takaesu N., Barth K.S., Kispert A., Herrmann B., et al. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 1994, 120:1919-1928.
42. Nomura M., Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998, 393:786-790.
43. Song J., Oh S.P., Schrewe H., Nomura M., Lei H., Okano M., et al. The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev Biol 1999, 213:157-169.
44. Ogawa K., Saito A., Matsui H., Suzuki H., Ohtsuka S., Shimosato D., et al. Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells. J Cell Sci 2007, 120:55-65.
45. Vallier L., Reynolds D., Pedersen R.A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 2004, 275:403-421.
46. Sakaki-Yumoto M., Liu J., Ramalho-Santos M., Yoshida N., Derynck R. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state. J Biol Chem 2013, 288:18546-18560.
47. Brandenberger R., Wei H., Zhang S., Lei S., Murage J., Fisk G.J., et al. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol 2004, 22:707-716.
48. Inman G.J., Nicolás F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002, 62:65-74.
49. Ying Q.L., Smith A.G. Defined conditions for neural commitment and differentiation. Methods Enzymol 2003, 365:327-341.
50. Ying Q.L., Stavridis M., Griffiths D., Li M., Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003, 21:183-186.
51. Paling N.R., Wheadon H., Bone H.K., Welham M.J. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 2004, 279:48063-48070.
52. Qi X., Li T.G., Hao J., Hu J., Wang J., Simmons H., et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 2004, 101:6027-6032.
53. Wilson P.A., Hemmati-Brivanlou A. Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 1995, 376:331-333.
54. Yasunaga M., Tada S., Torikai-Nishikawa S., Nakano Y., Okada M., Jakt L.M., et al. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005, 23:1542-1550.
55. Gadue P., Huber T.L., Paddison P.J., Keller G.M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci USA 2006, 103:16806-16811.
56. Fei T., Xia K., Li Z., Zhou B., Zhu S., Chen H., et al. Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determination. Genome Res 2010, 20:36-44.
57. Weidgang C.E., Russell R., Tata P.R., Kühl S.J., Illing A., Müller M., et al. TBX3 directs cell-fate decision toward mesendoderm. Stem Cell Report 2013, 1:248-265.
58. Xiao L., Yuan X., Sharkis S.J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 2006, 24:1476-1486.
59. Richer A., Valdimarsdittur L., Hrafnkelsdotiir H.E., Runarsson J.F., Omarsdottir A.R., Oostward D.W., et al. BMP4 promotes EMT and mesodermal commitment in human embryonic stem cells via SLUG and MSX1. Stem Cells 2014, 32:636-648.
60. Tam P.P., Behringer R.R. Mouse gastrulation: the formation of a mammalian body plan. Mech Dev 1997, 68:3-25.
61. Nostro M.C., Cheng X., Keller G.M., Gadue P. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2008, 2:60-71.
62. Kimura-Yoshida C., Nakano H., Okamura D., Nakao K., Yonemura S., Belo J.A., et al. Canonical Wnt signaling and its antagonist regulate anterior-posterior axis polarization by guiding cell migration in mouse visceral endoderm. Dev Cell 2005, 9:639-650.
63. Kubo A., Shinozaki K., Shannon J.M., Kouskoff V., Kennedy M., Woo S., et al. Development of definitive endoderm from embryonic stem cells in culture. Development 2004, 131:1651-1662.
64. Gouon-Evans V., Boussemart L., Gadue P., Nierhoff D., Koehler C.I., Kubo A., et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006, 24:1402-1411.
65. Shiraki N., Yoshida T., Araki K., Umezawa A., Higuchi Y., Goto H., et al. Guided differentiation of embryonic stem cells into Pdx1-expressing regional-specific definitive endoderm. Stem Cells 2008, 26:874-885.
66. Yi P., Park J.S., Melton D.A. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 2013, 153:747-758.
67. Singbrant S., Karlsson G., Ehinger M., Olsson K., Jaako P., Miharada K., et al. Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture. Blood 2010, 115:4689-4698.
68. Trompouki E., Bowman T.V., Lawton L.N., Fan Z.P., Wu D.C., DiBiase A., et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 2011, 147:577-589.
69. Behfar A., Zingman L.V., Hodgson D.M., Rauzier J.M., Kane G.C., Terzic A., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002, 16:1558-1566.
70. Chi X., Chatterjee P.K., Wilson W., Zhang S.X., Demayo F.J., Schwartz R.J. Complex cardiac Nkx2-5 gene expression activated by noggin-sensitive enhancers followed by chamber-specific modules. Proc Natl Acad Sci USA 2005, 102:13490-13495.
71. Willems E., Cabral-Teixeira J., Schade D., Cai W., Reeves P., Bushway P.J., et al. Small molecule-mediated TGFβtype II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cells 2012, 11:242-252.
72. Mizuseki K., Sakamoto T., Watanabe K., Muguruma K., Ikeya M., Nishiyama A., et al. Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells. Proc Natl Acad Sci USA 2003, 13:5828-5833.
73. Kamiya D., Banno S., Sasai N., Ohgushi M., Inomata H., Watanabe K., et al. Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature 2011, 470:503-509.
74. Gossrau G., Thiele J., Konang R., Schmandt T., Brüstle O. Bone morphogenetic protein-mediated modulation of lineage diversification during neural differentiation of embryonic stem cells. Stem Cells 2007, 25:939-949.
75. Schulz T.C., Noggle S.A., Palmarini G.M., Weiler D.A., Lyons I.G., Pensa K.A., et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 2004, 22:1218-1238.
76. Pera M.F., Andrade J., Houssami S., Reubinoff B., Trounson A., Stanley E.G., et al. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J Cell Sci 2004, 117:1269-1280.
77. Zhou J., Su P., Li D., Tsang S., Duan E., Wang F. High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 2010, 28:1741-1750.
78. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009, 27:275-280.
79. Morizane A., Doi D., Kikuchi T., Nishimura K., Takahashi J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res 2011, 89:117-126.
80. Greber B., Coulon P., Zhang M., Moritz S., Frank S., Müller-Molina A.J., et al. FGF signaling inhibits neural induction in human embryonic stem cells. EMBO J 2011, 30:4874-4884.
81. Ying Y., Zhao G.Q. Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse. Dev Biol 2001, 232:484-492.
82. Fujiwara T., Dunn N.R., Hogan B.L.M. Bone morphogenetic protein 4 in the extraembryonic mesoderm is required for allantois development and the localization and survival of primordial germ cells in the mouse. Proc Natl Acad Sci USA 2001, 24:13739-13744.
83. Ying Y., Liu X.M., Marble A., Lawson K.A., Zhao G.Q. Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol 2000, 14:1053-1063.
84. Saitou M., Barton S.C., Surani M.A. A molecular programme for the specification of germ cell fate in mice. Nature 2002, 418:293-300.
85. Aramaki S., Hayashi K., Kurimoto K., Ohta H., Yabuta Y., Iwanari H., et al. A mesodermal factor, T, specifies mouse germ cell fate by directly activating germline determinants. Dev Cell 2013, 27:516-529.
86. Toyooka Y., Tsunekawa N., Akasu R., Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci USA 2003, 100:11457-11462.
87. Wei W., Qing T., Ye X., Liu H., Zhang D., Yang W., et al. Primordial germ cell specification from embryonic stem cells. PLoS One 2008, 3:e4013.
88. Kee K., Gonsalves J.M., Clark A.T., Pera R.A. Bone morphogenetic proteins induce germ cell differentiation from human embryonic stem cells. Stem Cells Dev 2006, 15:831-837.
89. Panula S., Medrano J.V., Kee K., Bergström R., Nguyen H.N., Byers B., et al. Human germ cell differentiation from fetal- and adult-derived induced pluripotent stem cells. Hum Mol Genet 2011, 20:752-762.
90. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
91. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
92. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009, 460:49-52.
93. Bauman K. Stem cells: holding onto the memories. Nat Rev Genet 2010, 11:593.
94. Lin T., Ambasudhan R., Yuan X., Li W., Hilcove S., Abujarour R., et al. A chemical platform for improved induction of human iPSCs. Nat Methods 2009, 6:805-808.
95. Ichida J.K., Blanchard J., Lam K., Son E.Y., Chung J.E., Egli D., et al. A small-molecule inhibitor of Tgf-β signaling replaces sox2 in reprogramming by inducing Nanog. Cell Stem Cell 2009, 5:491-503.
96. Liu X., Sun H., Qi J., Wang L., He S., Liu J., et al. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol 2013, 15:829-838.
97. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.